Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China

References

• Zhou Y, Lauschke VM. Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews. J Med Genet. 2018;55(9):617–627. doi:10.1136/jmedgenet-2018-105429
   PubMed Web of Science ®Google Scholar
• Li J, Lou H, Yang X, et al. Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy. J Med Genet. 2014;51(9):614–622. doi:10.1136/jmedgenet-2014-102530
   Web of Science ®Google Scholar
• Donaldson LJ, Kelley ET, Dhingra-Kumar N, et al. Medication without harm: WHO’s Third global patient safety challenge. Lancet. 2017;389(10080):1680–1681. doi:10.1016/S0140-6736(17)31047-4
   PubMed Web of Science ®Google Scholar
• Wester K, Jonsson AK, Spigset O, et al. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65(4):573–579. doi:10.1111/j.1365-2125.2007.03064.x
   PubMed Web of Science ®Google Scholar
• Chowbay B, Zhou S, Lee EJD. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore. Drug Metab Rev. 2005;37(2):327–378. doi:10.1081/DMR-28805
   PubMed Web of Science ®Google Scholar
• Zuo LJ, Guo T, Xia DY, et al. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations. Genet Test Mol Biomarkers. 2012;16(2):102–108. doi:10.1089/gtmb.2011.0084
   PubMed Web of Science ®Google Scholar
• Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet. 2001;27(4):383–391. doi:10.1038/86882
   PubMed Web of Science ®Google Scholar
• Zhang C, Jiang X, Chen W, et al. Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province. Medicine. 2018;97(52):e13674. doi:10.1097/MD.0000000000013674
   Web of Science ®Google Scholar
• Jin T, Zhao R, Shi X, et al. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China’s Shaanxi province. Environ Toxicol Pharmacol. 2016;46:27–35. doi:10.1016/j.etap.2016.06.026
   Web of Science ®Google Scholar
• McGraw J, Waller D. Cytochrome P450 variations in different ethnic populations. Expert Opin Drug Metab Toxicol. 2012;8(3):371–382. doi:10.1517/17425255.2012.657626
   PubMed Web of Science ®Google Scholar
• Magalon H, Patin E, Austerlitz F, et al. Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia. Eur J Hum Genet. 2008;16(2):243–251. doi:10.1038/sj.ejhg.5201963
   Web of Science ®Google Scholar
• Sun B, Wen YF, Culhane-Pera KA, et al. Differences in predicted warfarin dosing requirements between Hmong and East Asians using genotype-based dosing algorithms. Pharmacotherapy. 2021;41(3):265–76. doi:10.1002/phar.2487
   Web of Science ®Google Scholar
• Yan M, Li D, Zhao G, et al. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China. Gene. 2018;648:54–62. doi:10.1016/j.gene.2018.01.040
   Web of Science ®Google Scholar
• Deeken JF, Cormier T, Price DK, et al. A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J. 2010;10(3):191–199. doi:10.1038/tpj.2009.57
   PubMed Web of Science ®Google Scholar
• Rajman I, Knapp L, Morgan T, et al. African genetic diversity: implications for cytochrome P450-mediated drug metabolism and drug development. EBioMedicine. 2017;17:67–74. doi:10.1016/j.ebiom.2017.02.017
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Clin Pharmacol Ther. 2013;138(1):103–141.
   Google Scholar
• Jin T, Aikemu A, Zhang M, et al. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Miao ethnic group of Southwest China. Med Sci Monit. 2015;21:3769–3776. doi:10.12659/MSM.895191
   Web of Science ®Google Scholar
• Zhang J, Jin T, Yunus Z, et al. Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China. BMC Genet. 2014;15(1):102. doi:10.1186/s12863-014-0102-y
   Web of Science ®Google Scholar
• Gudbjartsson DF, Helgason H, Gudjonsson SA, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47(5):435–444. doi:10.1038/ng.3247
   PubMed Web of Science ®Google Scholar
• Hehir-Kwa JY, Marschall T, Kloosterman WP, et al. A high-quality human reference panel reveals the complexity and distribution of genomic structural variants. Nat Commun. 2016;7(1):12989. doi:10.1038/ncomms12989
   Web of Science ®Google Scholar
• MacArthur J, Bowler E, Cerezo M, et al. The new NHGRI-EBI catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 2017;45(D1):D896–D901. doi:10.1093/nar/gkw1133
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhang C, Yuan L, et al. PGG.Han: the Han Chinese genome database and analysis platform. Nucleic Acids Res. 2020;48(D1):D971–D6. doi:10.1093/nar/gkz829
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang H, Niu G, et al. Deciphering DMET genetic data: comprehensive assessment of Northwestern Han, Tibetan, Uyghur populations and their comparison to eleven 1000 genome populations. Artif Cell Nanomed B. 2019;46(sup3):S1176–S85. doi:10.1080/21691401.2018.1533849
   Web of Science ®Google Scholar
• Chen W, Ding H, Cheng Y, et al. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China. Mol Genet Genomic Med. 2019;7(9):e884. doi:10.1002/mgg3.884
   Web of Science ®Google Scholar
• Rodrigues JCG, Fernandes MR, Guerreiro JF, et al. Polymorphisms of ADME-related genes and their implications for drug safety and efficacy in Amazonian Amerindians. Sci Rep. 2019;9(1):1–8.
   PubMed Web of Science ®Google Scholar
• Maisano Delser P, Fuselli S. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications. Hum Genet. 2013;132(5):563–577. doi:10.1007/s00439-013-1268-5
   Web of Science ®Google Scholar
• Zhou Y, Ingelman-Sundberg M, Lauschke VM. Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects. Clin Pharmacol Ther. 2017;102(4):688–700. doi:10.1002/cpt.690
   PubMed Web of Science ®Google Scholar
• Kozyra M, Ingelman-Sundberg M, Lauschke VM. Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response. Genet Med. 2017;19(1):20–29. doi:10.1038/gim.2016.33
   PubMed Web of Science ®Google Scholar
• Abecasis GR, Auton A, Brooks LD, et al.; Genomes Project C. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491(7422):56–65.
   PubMed Web of Science ®Google Scholar
• Zhou S-F, Liu J-P, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41(2):89–295.
   PubMed Web of Science ®Google Scholar
• Al-Eitan LN, Rababa’h DM, Hakooz NM, et al. Genetic polymorphisms of pharmacogenes among the genetically isolated Circassian subpopulation from Jordan. J Pers Med. 2020;10(1):2. doi:10.3390/jpm10010002
   Web of Science ®Google Scholar
• Jaja C, Burke W, Thummel K, et al. Cytochrome p450 enzyme polymorphism frequency in indigenous and native American populations: a systematic review. Community Genet. 2008;11(3):141–149.
   PubMedGoogle Scholar
• Huo R, Tang K, Wei Z, et al. Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population. PLoS One. 2012;7(5):e34809. doi:10.1371/journal.pone.0034809
   PubMed Web of Science ®Google Scholar
• Relling MV, Klein TE. CPIC: Clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011;89(3):464–467. doi:10.1038/clpt.2010.279
   PubMed Web of Science ®Google Scholar
• Geisen C, Watzka M, Sittinger K, et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost. 2005;94(4):773–779.
   PubMed Web of Science ®Google Scholar
• Askari B, Khaleqsefat E, Khalafkhani D, Khalaj-Kondori M, Khademvatan K, Soraya H. Study on a novel polymorphism in the VKORC1 promoter region using bioinformatic tools and warfarin dosing data. Thromb Res. 2017;158:76–78. doi:10.1016/j.thromres.2017.08.012
   Web of Science ®Google Scholar
• Peng L. An overview of the seed origin myths of the Chinese Altaic language family ethnic group. J Hulunbuir Univ. 2021;29(3):143–148.
   Google Scholar
• Zhang H, De T, Zhong Y, Perera MA. The advantages and challenges of diversity in pharmacogenomics: can minority populations bring us closer to implementation? Clin Pharmacol Ther. 2019;106(2):338–349. doi:10.1002/cpt.1491
   Web of Science ®Google Scholar